Talk:SAV001

AIDS Low‑importance

	This article is part of WikiProject AIDS, an attempt to build a comprehensive, detailed, and accessible guide to AIDS, HIV, and related topics on Wikipedia. If you would like to participate in the project, you can choose to edit this article, or visit the project page for more information.AIDSWikipedia:WikiProject AIDSTemplate:WikiProject AIDSAIDS articles
Low	This article has been rated as Low-importance on the project's importance scale.

Medicine Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Low	This article has been rated as Low-importance on the project's importance scale.

I added the "reads like a news release" banner

There are some notable things about this vaccine -- it is the first to use actual virions and the first round of trials will have study participants who are already HIV+ -- but none of that is mentioned in this article. This seems to be nothing more than self promotion. If we cannot get knowledgeable editors to bring this article up to standards, I will recommend that it be deleted. TechBear | Talk | Contributions 15:10, 3 January 2013 (UTC)[reply]

Phase II trials are "due to begin in 2014", but there is no evidence they ever did.

The sumagen.co.kr/english website doesn't even state that the Phase I trials were successful. I agree that this article should be updated (if the current information is useful) or deleted. Davedecot (talk) 21:25, 13 September 2015 (UTC)[reply]